Latest news

SCI Ventures invests in big pharma-backed biotech ViaNautis to create regenerative treatments for chronic SCI

Cyllene Therapeutics Raises €33 Million Series C

Craig Hospital joins SCI Ventures as Alliance Partner

NervGen Pharma successfully raised US$60 million through a public offering

NervGen announces $10M private placement for anticipated Nasdaq listing with SCI Ventures' support

Major BCI firm Precision Neuroscience inks partnership with SCI Ventures

"Superman" backed Fund partners with Healx AI to fight Paralysis

EG 427 is dosing first SCI patient in clinical trial for neurogenic bladder

SCI Ventures backs EG 427 for clinical trial in SCI bladder dysfunction

Managing Partner Adrien Cohen on French National Business TV BFM about SCI Ventures

Why five spinal cord injury organizations teamed up to launch a new venture philanthropy fund

SCI Ventures Launches Venture Philanthropy Fund to Accelerate Restorative Treatments for Spinal Cord Injury and a Cure for Paralysis

Charities create fund to invest in spinal cord injury companies

Sania Therapeutics presents latest from AAV gene therapy platform at the American Society of Gene & Cell Therapy Annual Meeting

Augmental wins Best Pitch at CES 2024

Musk touts Neuralink's first patient as a big step. Experts say it's part of long legacy.